These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 7933609

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Short- and long-term effects of the new oral prostacyclin analogue, beraprost sodium, in patients with severe pulmonary hypertension].
    Saji T, Ozawa Y, Nakayama T, Matsuura H, Hashiguchi R, Matsuo N, Muto H, Yamazaki J, Morishita T, Saito T.
    J Cardiol; 1996 Apr; 27(4):197-205. PubMed ID: 8642506
    [Abstract] [Full Text] [Related]

  • 25. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
    Yajima M, Baba K, Minagawa N, Kohno S, Haraguchi C, Iwamoto T, Osada T.
    Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
    [Abstract] [Full Text] [Related]

  • 26. [Results of the treatment of peripheral arterial diseases with PGE1].
    Borkowski M, Kruk M, Królicki L, Wojtal E, Malmurowicz L, Górewicz R, Laszuk D.
    Pol Tyg Lek; 1993 Mar; 45(25-26):505-8. PubMed ID: 2287566
    [Abstract] [Full Text] [Related]

  • 27. [Development of new drugs for intractable vasculitis--lipo-PGE1 and monoclonal antibody].
    Matsuda T, Hoshi K, Igarashi R, Ichikawa Y.
    Nihon Rinsho; 1994 Aug; 52(8):2187-91. PubMed ID: 7933610
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A preliminary double-blind cross-over trial of lipo-PGI2, a prostacyclin derivative incorporated in lipid microspheres, in cerebral infarction.
    Hoshi K, Mizushima Y.
    Prostaglandins; 1990 Aug; 40(2):155-64. PubMed ID: 2217831
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Interaction between non-ionic contrast medium and prostaglandin E1 incorporated in lipid microspheres: in-vitro comparative study of direct and non-direct mixing.
    Hayashi H, Uchiyama N, Kawamata H, Takagi R, Abe Y, Kumazaki T.
    Radiat Med; 2000 Aug; 18(4):219-25. PubMed ID: 11246996
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The intrainfusion platelet rebound during and following PGE1-infusion is faster and more intensive than that with PGI2.
    Sinzinger H, Reiter S.
    Prostaglandins Leukot Med; 1984 Mar; 13(3):281-8. PubMed ID: 6585847
    [Abstract] [Full Text] [Related]

  • 36. [Analysis of costs and results of prostaglandin (PGE1 alpha-cyclodestrin) therapy of peripheral arterial diseases].
    Bucci M, Iacobitti P, Laurora G, Cesarone MR.
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):9-15. PubMed ID: 10658439
    [Abstract] [Full Text] [Related]

  • 37. Lipid microspheres as novel drug carriers.
    Mizushima Y.
    Drugs Exp Clin Res; 1985 Oct; 11(9):595-600. PubMed ID: 3880046
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.